MedTrace Logo

The Risks of Percutaneous Native Kidney Biopsy in Italy: a Prospective Cohort Study

NCT04948593 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 5304

Last updated 2021-07-02

No results posted yet for this study

Summary

The estimates risks and benefits of the percutaneous kidney biopsy have been reported mainly from retrospective studies. So far no prospective multicentre studies has been designed to identify rates of biopsy related complications. The aim of this prospective multicentre study was to evaluate safety and complication events related to biopsies on native kidney in Italy.

Conditions

Interventions

PROCEDURE

Native kidney biopsy

Sponsors & Collaborators

  • Simeone Andrulli, MD

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-01-03
Primary Completion
2020-08-04
Completion
2021-05-31

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04948593 on ClinicalTrials.gov